University of Michigan Health
David T. Broome, MD, MSc, is an adult Clinical Assistant Professor of Medicine and Caswell Diabetes Institute Clinical and Translational Research Scholar at the University of Michigan. Dr. Broome's research is in type 1 diabetes (T1D) screening & prevention, conducting clinical trials for novel therapeutics in diabetes, and Maturity Onset Diabetes of the Young (MODY). He currently is an investigator for several NIH/NIDDK and industry sponsored clinical trials dedicated to T1D screening & prevention, and MODY-Monogenic [including TrialNet, the Rare and Atypical Diabetes Network (RADIANT), βETA PRESERVE, and An Observational, Long-Term Safety Study of TZIELD (teplizumab-mzwv) in Patients with Stage 2 Type 1 Diabetes, PRECIDENTD], and Co-Chairs the PREcision DIabetes ConsorTium (PREDICT; which is the largest multi-center MODY data collaboration agreement in the United States). He was the recipient of several teaching and research awards and currently serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare, and on the editorial board for the Journal of Clinical Endocrinology & Metabolism (JCEM).